Preskoči na vsebino

Onkologija (pediatrija)

Individualized/Modified Chemotherapy (Dose Adjustment or Delay)

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. (odpre novo okno)

Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH

Vir‎: N Engl J Med 1998;338(8):499-505.

Indeksirano‎: PubMed 9468466

DOI‎: 10.1056/NEJM199802193380803

https://www.ncbi.nlm.nih.gov/pubmed/9468466 (odpre novo okno)

Childhood cancer and the Jehovah's Witness faith. (odpre novo okno)

Frankel LS, Damme CJ, Eys JV.

Vir‎: Pediatrics 1977;60(6):916-21.

Indeksirano‎: PubMed 600607

https://www.ncbi.nlm.nih.gov/pubmed/600607 (odpre novo okno)

Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma. (odpre novo okno)

Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK

Vir‎: J Clin Oncol 2004;22(24):4888-92.

Indeksirano‎: PubMed 15611504

DOI‎: 10.1200/JCO.2004.02.101

https://www.ncbi.nlm.nih.gov/pubmed/15611504 (odpre novo okno)

Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group AAML1331 Trial. (odpre novo okno)

Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Wang YC, Hirsch BA, Raimondi S, Kahwash S, Hardy KK, Hardy S, Meshinchi S, Gamis AS, Kolb EA, Feusner JH, Gregory J Jr

Vir‎: JAMA Oncol 2022;8(1):79-87. 

Indeksirano‎: PubMed 34762093

DOI‎: 10.1001/jamaoncol.2021.5206

https://pubmed.ncbi.nlm.nih.gov/34762093/ (odpre novo okno)

Acute leukemia in Jehovah's Witnesses: a challenge for hematologists. (odpre novo okno)

Mazza P, Palazzo G, Amurri B, Cervellera M, Rizzo C, Maggi A

Vir‎: Haematologica 2000;85(11):1221-2.

Indeksirano‎: PubMed 11064477

https://www.ncbi.nlm.nih.gov/pubmed/11064477 (odpre novo okno)

Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients. (odpre novo okno)

Mazza P, Palazzo G, Minoia C, Amurri B, Pisapia G

Vir‎: Bone Marrow Transplant 2016;51(7):1002-3.

Indeksirano‎: PubMed 26950381

DOI‎: 10.1038/bmt.2016.29

https://www.ncbi.nlm.nih.gov/pubmed/26950381 (odpre novo okno)

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (odpre novo okno)

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

Vir‎: Bone Marrow Transplant 2003;32(4):433-6.

Indeksirano‎: PubMed 12900781

DOI‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 (odpre novo okno)

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (odpre novo okno)

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

Vir‎: Bone Marrow Transplant 2005;36(8):715-20.

Indeksirano‎: PubMed 16113672

DOI‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 (odpre novo okno)

Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia. (odpre novo okno)

Zwaan CM, Kaspers GJ

Vir‎: Br J Haematol 2004;127(3):264-79.

Indeksirano‎: PubMed 15491285

DOI‎: 10.1111/j.1365-2141.2004.05167.x

https://www.ncbi.nlm.nih.gov/pubmed/15491285 (odpre novo okno)